600664:SHA
Harbin Pharmaceutical Group Co Ltd
CN¥6.29
arrow_upward
+1.62%(+0.100) 1D
Oct 16, 2:54:22 PM GMT+8 · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 600664...
Open
CN¥6.26
High
CN¥6.77
Low
CN¥6.19
Mkt. cap
16.52B
Avg. vol.
387.14M
Volume
401.13M
P/E ratio
30.93
52-wk high
CN¥9.86
52-wk low
CN¥2.84
EPS
CN¥0.20
Shares outstanding
2.54B
No. of employees
10K
Open
CN¥6.26
High
CN¥6.77
Low
CN¥6.19
Mkt. cap
16.52B
Avg. vol.
387.14M
Volume
401.13M
P/E ratio
30.93
52-wk high
CN¥9.86
52-wk low
CN¥2.84
EPS
CN¥0.20
Shares outstanding
2.54B
No. of employees
10K
News stories
From web sources and news partners
Benzinga
·
14 minutes ago
Dow Jumps Over 550 Points Following Economic Data: Investor Sentiment Improves, But Fear & Greed Index Re
Yahoo Finance
·
31 minutes ago
Stock Market: Will S&P 500 Open Up or Down Today?
Trefis
·
1 hour ago
17 S&P 500 Stocks Just Made New 52-Week Highs
The Motley Fool
·
4 hours ago
The S&P 500 Went More Than 50 Trading Days Without a 1% Drop. That Streak Just Ended. What's Next?
Profile
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.
The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia
About Harbin Pharmaceutical Group Co Ltd